Powder containment and aseptic transfer valve specialist, ChargePoint Technology, has advanced its unique smart monitoring solution, VERIFI, to support the biopharma market.
The VERIFI intelligent monitoring platform is the first technology of its kind and is used to monitor usage data for ChargePoint’s split butterfly valves (SBVs).
By recording how many times the valve has been used and monitoring its temperature, VERIFI generates data that allows operators and health & safety teams to manage the maintenance of their containment solution. Ultimately, this helps to improve efficiency and safety within chemical and pharmaceutical manufacturing processes.
Malcolm Cunningham, Head of Sales EMEIA and LATAM at ChargePoint said: “VERIFI gives manufacturers an automatic and reliable method of understanding the health status of their valves so that they can take preventative action. This in turn improves operational performance, productivity and helps to manage risk.
“The response from customers in the pharma market so far has been excellent. VERIFI is not only giving the user confidence in the operational performance of SBV technology, but also the safety and quality teams peace of mind.”
The software advancements now available with the VERIFI hub mean that it can connect directly onto the ChargePoint AseptiSafe valve unit, which is used to ensure sterility during aseptic processing. The data is then accessed from the device itself or remotely via an online dashboard.
Malcolm continued: “We are thrilled to be able to service the biopharma market. Given the growth in the biotech sector, extending the application of VERIFI to this market is a natural next step for us. By adding unique technologies such as VERIFI to our portfolio, we are putting ChargePoint Technology at the forefront of overcoming sterile manufacturing challenges.”
ChargePoint Technology is the market leader in powder containment and aseptic transfer valves providing operator safety and sterility assurance for the pharmaceutical, biotech, chemical and other process industries. Its client portfolio includes some of the top 10 pharmaceutical companies and reaches into North America, UK, Europe, China and India, amongst others.
ChargePoint Technology manufactures its cutting-edge devices in its purpose-built facility in Liverpool, UK, employs more than 60 employees across the globe and secured a multi-million-pound investment from LDC, part of Lloyds Banking Group in January 2017, to meet the increase in global demand for its products and solutions.
The product range includes:
ChargePoint PharmaSafe® – Powder containment valves offering the highest levels of containment performance for HPAPIs
ChargePoint AseptiSafe® – Aseptic transfer valves offering sterility insurance for sterile APIs
ChargePoint AfterCare™ – Dedicated team offering installation and maintenance training and onsite support, as well as spare parts and accessories.
ChargeBag® – Single use bags for contained transfer of powder and small process components
ChargeBottle® – Small scale rigid containers to suit a variety of process requirements.
